Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-intensified Rechallenge With Temozolomide, One Week On One Week Off Versus Three Weeks On One Week Off in Patients With Progressive or Recurrent Glioblastoma

NCT00941460 is registered in ClinicalTrials.gov with Prof. Dr. Wolfgang Wick as lead sponsor.

NCT NCT00941460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00941460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-intensified Rechallenge With Temozolomide, One Week On One Week Off Versus Three Weeks On One Week Off in Patients With Progressive or Recurrent Glioblastoma
Lead sponsor
Prof. Dr. Wolfgang Wick
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
June 30, 2013
Enrollment
105 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma